Long-Term Persistence and Monotherapy with Device-Aided Therapies: A Retrospective Analysis of an Israeli Cohort of Patients with Advanced Parkinson’s Disease

INTRODUCTION: Patients with advanced Parkinson’s disease (PD) may require device-aided therapies (DAT) for adequate symptom control. However, long-term, real-world efficacy and safety data are limited. This study aims to describe real-world, long-term treatment persistence for patients with PD treat...

Descripción completa

Detalles Bibliográficos
Autores principales: Thaler, Avner, Barer, Yael, Gross, Ruth, Cohen, Raanan, Bergmann, Lars, Jalundhwala, Yash J., Giladi, Nir, Chodick, Gabriel, Shalev, Varda, Gurevich, Tanya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9056469/
https://www.ncbi.nlm.nih.gov/pubmed/35247187
http://dx.doi.org/10.1007/s12325-022-02072-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9056469/
https://www.ncbi.nlm.nih.gov/pubmed/35247187
http://dx.doi.org/10.1007/s12325-022-02072-x

Ejemplares similares